Park occupier Isomerase have been awarded the Queen's Award for Enterprise in International Trade. The Queen’s Award is the most prestigious corporate achievement that any UK business can attain and is a seal of approval for outstanding performance.

The company operates a dual business model offering fee-for-service contract research to global pharma partners, reinvesting the profits from this activity into the development of a proprietary suite of novel drug discovery technologies which have the potential to deliver a new generation of medicines for the treatment of cancer and infectious disease. 

Dr Matt Gregory (CEO) and Dr Steven Moss (CTO) co-founded and have managed the company from its formation in 2012 to its current position. The company's overseas sales have grown by over 600% during the last three years with strong relationships built with companies across the globe. It employs over 20 highly skilled staff.  The team at Isomerase works with partners to help them discover and develop Microbial Natural Products.

Dr Matt Gregory stated “The Queen’s Award reflects the exceptional science we do and our commitment to innovation, investment in UK science and in global collaborations.”

Click here to find out more about Isomerase.